BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Rawe M, Kilmister EJ, Mantamadiotis T, Kaye AH, Tan ST, Wickremesekera AC. The Renin-Angiotensin System in the Tumor Microenvironment of Glioblastoma. Cancers (Basel) 2021;13:4004. [PMID: 34439159 DOI: 10.3390/cancers13164004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Kilmister EJ, Koh SP, Weth FR, Gray C, Tan ST. Cancer Metastasis and Treatment Resistance: Mechanistic Insights and Therapeutic Targeting of Cancer Stem Cells and the Tumor Microenvironment. Biomedicines 2022;10:2988. [DOI: 10.3390/biomedicines10112988] [Reference Citation Analysis]
2 Torres ID, Loureiro JA, Coelho MAN, Carmo Pereira M, Ramalho MJ. Drug delivery in glioblastoma therapy: a review on nanoparticles targeting MGMT-mediated resistance. Expert Opinion on Drug Delivery. [DOI: 10.1080/17425247.2022.2124967] [Reference Citation Analysis]
3 Kilmister EJ, Tan ST. Insights Into Vascular Anomalies, Cancer, and Fibroproliferative Conditions: The Role of Stem Cells and the Renin-Angiotensin System. Front Surg 2022;9:868187. [DOI: 10.3389/fsurg.2022.868187] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 O'Rawe M, Wickremesekera AC, Pandey R, Young D, Sim D, FitzJohn T, Burgess C, Kaye AH, Tan ST. Treatment of glioblastoma with re-purposed renin-angiotensin system modulators: Results of a phase I clinical trial. J Clin Neurosci 2022;95:48-54. [PMID: 34929651 DOI: 10.1016/j.jocn.2021.11.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Stylli SS. Novel Treatment Strategies for Glioblastoma-A Summary. Cancers (Basel) 2021;13:5868. [PMID: 34831020 DOI: 10.3390/cancers13225868] [Reference Citation Analysis]